^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    GenoPredicta™

    Company:
    Predicta Biosciences
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    GenoPredicta™ employs whole genome sequencing (WGS) to detect genomic alterations in tumor cells obtained from either the bone marrow or circulating tumor cells from peripheral blood of Multiple Myeloma (MM) patients or related plasma cell dyscrasias, such as Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Myeloma and Amyloidosis or other related disorders.
    Cancer:
    Multiple Myeloma
    Method:
    Whole Genome sequencing